Observational studyJournal of the International Association of Providers of AIDS Care

Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients.

Niccolò Riccardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.